Telsey Advisory Group Forecasts Birkenstock Q2 Earnings

Birkenstock Holding plc (NYSE:BIRK) – Stock analysts at Telsey Advisory Group issued their Q2 2025 earnings estimates for Birkenstock in a research report issued to clients and investors on Thursday, December 19th. Telsey Advisory Group analyst D. Telsey anticipates that the company will earn $0.54 per share for the quarter. Telsey Advisory Group currently has a “Outperform” rating and a $70.00 target price on the stock. The consensus estimate for Birkenstock’s current full-year earnings is $1.36 per share. Telsey Advisory Group also issued estimates for Birkenstock’s Q3 2025 earnings at $0.65 EPS, Q4 2025 earnings at $0.37 EPS and FY2025 earnings at $1.71 EPS.

BIRK has been the topic of a number of other reports. Robert W. Baird boosted their price objective on Birkenstock from $65.00 to $72.00 and gave the company an “outperform” rating in a research report on Thursday, December 19th. Piper Sandler assumed coverage on shares of Birkenstock in a report on Tuesday, December 10th. They issued an “overweight” rating and a $65.00 price target on the stock. Hsbc Global Res upgraded shares of Birkenstock to a “strong-buy” rating in a research note on Tuesday, December 3rd. BTIG Research lifted their target price on shares of Birkenstock from $60.00 to $70.00 and gave the company a “buy” rating in a research report on Wednesday, December 18th. Finally, BMO Capital Markets increased their price target on shares of Birkenstock from $60.00 to $70.00 and gave the stock an “outperform” rating in a research report on Thursday, December 19th. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $68.31.

Birkenstock Trading Up 0.4 %

Shares of BIRK opened at $60.15 on Monday. The stock’s 50-day moving average price is $50.53 and its 200 day moving average price is $53.04. The company has a quick ratio of 1.49, a current ratio of 2.91 and a debt-to-equity ratio of 0.55. The firm has a market capitalization of $11.30 billion, a price-to-earnings ratio of 98.61, a P/E/G ratio of 1.19 and a beta of 2.22. Birkenstock has a 12-month low of $41.00 and a 12-month high of $64.78.

Institutional Trading of Birkenstock

A number of hedge funds and other institutional investors have recently made changes to their positions in BIRK. Bamco Inc. NY grew its holdings in Birkenstock by 2.6% during the 3rd quarter. Bamco Inc. NY now owns 3,102,507 shares of the company’s stock worth $152,923,000 after acquiring an additional 78,093 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of Birkenstock by 30.4% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,000,000 shares of the company’s stock valued at $163,230,000 after purchasing an additional 700,000 shares during the last quarter. FMR LLC increased its holdings in shares of Birkenstock by 61.4% in the third quarter. FMR LLC now owns 2,128,689 shares of the company’s stock valued at $104,923,000 after purchasing an additional 809,784 shares in the last quarter. Millennium Management LLC bought a new position in Birkenstock in the 2nd quarter worth approximately $61,972,000. Finally, Federated Hermes Inc. lifted its holdings in Birkenstock by 42.0% during the 2nd quarter. Federated Hermes Inc. now owns 1,071,235 shares of the company’s stock worth $58,286,000 after buying an additional 316,935 shares in the last quarter. 19.93% of the stock is currently owned by institutional investors and hedge funds.

Birkenstock Company Profile

Birkenstock Holding plc manufactures and sells footwear products. It also offers sandals, shoes, closed-toe silhouettes, skincare products, and accessories. The company sells its products through e-commerce sites and a network of owned retail stores, as well as business-to-business channels. It operates in the United States, Brazil, Canada, Mexico, Europe, APMA, and internationally.